Rapid, standardized method for determination of Mycobacterium tuberculosis drug susceptibility by use of mycolic acid analysis

Journal of Clinical Microbiology

Volumn 45, Issue 12, 2007, Pages 3915-3920

  Parrish, Nicole ^a   Osterhout, Gerard ^a   Dionne, Kim ^a   Sweeney, Amy ^a   Kwiatkowski, Nicole ^a   Carroll, Karen ^a   Jost Jr , Kenneth C ^b   Dick, James ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; MYCOLIC ACID; PYRAZINAMIDE; RIFAMPICIN;

ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; DRUG SENSITIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METHODOLOGY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

ANTITUBERCULAR AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; MYCOLIC ACIDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 37249016440     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02528-06     Document Type: Article

References (9)

1. Banaiee, N., M. Bobadilla-del-Valle, P. F. Riska, S. Bardarov, Jr., P. M. Small, A. Ponce-de-Leon, W. R. Jacobs, Jr., G. F. Hatfull, and J. Sifuentes-Osnorio. 2003. Rapid identification and susceptibility testing of Mycobacterium tuberculosis from MGIT cultures with luciferase mycobacteriophages. J. Med. Microbiol. 52:557-561.
2. Blower, S. M., and T. Chou. 2004. Modeling the emergence of the 'hot zones': tuberculosis and the amplification dynamics of drug resistance. Nat. Med. 10:1111-1113.
3. Butler, W. R., and L. S. Guthertz. 2001. Mycolic acid analysis by high-performance liquid chromatography for identification of Mycobacterium species. Clin. Microbiol. Rev. 14:704-726.
4. Butler, W. R., K. C., Jost, Jr., and J. O. Kilburn. 1991. Identification of mycobacteria by high-performance liquid chromatography. J. Clin. Microbiol. 29:2468-2472.
5. Centers for Disease Control and Prevention. 2002. Global Tuberculosis. Proceedings of the Fourth National Conference on Laboratory Aspects of Tuberculosis. Centers for Disease Control and Prevention, Atlanta, GA.
6. Centers for Disease Control and Prevention. 2006. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs - worldwide, 2000-2004. Morb. Mortal. Wkly. Rep. 55:301-305.
7. Cohen, T., and M. Murray. 2004. Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness. Nat. Med. 10:1117-1121.
8. Dooley, S., W. Jarvis, W. Martone, and D. E. Snider, Jr. 1992. Multi-drug resistant tuberculosis. Ann. Intern. Med. 117:257-259.
9. Frieden, T., T. Sterling, A. Pablos-Mendez, J. O. Kilburn, G. M. Cauthen, and S.W. Dooley. 1993. The emergence of drug-resistant tuberculosis in New York City. N. Engl. J. Med. 328:521-526.